Evidence map›Paper›PMID 24648925›Full record

ArticleBiomedical reports2013

Detection of circulating tumour cells on mRNA levels with established breast cancer cell lines.

Michael Zebisch, Alexandra C Kölbl, Ulrich Andergassen, Stephan Hutter, Julia Neugebauer, Verena Engelstädter, Maria Günthner-Biller, Udo Jeschke, Klaus Friese, Brigitte Rack

Open access · bronzeAbstract read
In one paragraph

Article in Biomedical reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael ZebischDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Alexandra C KölblDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Ulrich AndergassenDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Stephan HutterDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Julia NeugebauerDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Verena EngelstädterDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Maria Günthner-BillerDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Udo JeschkeDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Klaus FrieseDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Brigitte RackDepartment of Obstetrics and Gynaecology, Ludwig-Maximilians University of Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumour cells were detected and quantified by real-time polymerase chain reaction (PCR) in peripheral blood, based on the fact that the expression of certain genes is upregulated in tumour tissues in comparison to surrounding blood cells. Calibration curves showing gene expression as functions of the number of tumour cells within a blood sample were prepared. Blood samples were therefore spiked with cells of breast cancer cell lines, RNA was extracted, transcribed to complementary DNA (cDNA) and used in real-time PCR reaction on the Cytokeratins (CK) 8, 18 and 19. Calibration curves were generated by Microsoft™ Excel®. Relative quantification curves of gene expression in different breast cancer cell lines showed no unitary tendencies. The oscillations in the relative quantification curves of gene expression suggested an occurrence of immunological effects, leading to an apparent agglutination of added tumour cells together with the blood cells of the sample. Thus, strategies to obtain evaluable results should be considered.

Indexed as

breast cancercirculating tumour cellsdetectionmRNAquantificationreal-time polymerase chain reaction

Identifiers

PMID24648925
PMCPMC3956213
OpenAlexW2009466289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.